ResearcherChina Pharmaceutical UniversityNo recent work listed

L Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7697-4854; OpenAlex author ID A5063889176. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2017: 1 paper

Papers 1

RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways. Co-author DOI 10.1038/onc.2016.306 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kan Ding · 1 shared paper, 2017 · strength 0.07
- Paper RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 … DOI 10.1038/onc.2016.306 ↗
Peng Li · 1 shared paper, 2017 · strength 0.07
- Paper RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 … DOI 10.1038/onc.2016.306 ↗
Chenghao Shao · 1 shared paper, 2017 · strength 0.07
- Paper RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 … DOI 10.1038/onc.2016.306 ↗
Yi Qin · 1 shared paper, 2017 · strength 0.07
- Paper RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 … DOI 10.1038/onc.2016.306 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.